Gilead Sciences Inc buy stefan
Start price
29.04.20
/
50%
€77.15
Target price
20.09.20
-
Performance (%)
-28.79%
End price
20.09.20
€54.94
Summary
This prediction ended on 20.09.20 with a price of €54.94. The price of Gilead Sciences Inc has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -28.79%. A total of €1.17 was paid as dividends for this prediction. stefan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Gilead Sciences Inc | -0.800% | -0.800% | -6.719% | 9.921% |
iShares Core DAX® | 3.054% | -1.396% | 15.789% | 12.675% |
iShares Nasdaq 100 | 4.389% | -5.391% | 29.906% | 39.325% |
iShares Nikkei 225® | 5.386% | -3.105% | 16.065% | 8.150% |
iShares S&P 500 | 2.955% | -3.011% | 25.903% | 37.650% |
Comments by stefan for this prediction
In the thread Gilead Sciences Inc diskutieren
Gibt wohl doch positive Nachrichten zum Corona Medikament
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/28/stock-market-futures-open-to-close-news.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
https://www.cnbc.com/2020/04/29/gilead-reports-positive-data-on-remdesivir-coronavirus-drug-trial.html?__source=iosappshare%7Ccom.apple.UIKit.activity.CopyToPasteboard
In the thread Trading Gilead Sciences Inc
Buy beendet